| 发明名称 |
Combination therapies using hdac inhibitors |
| 摘要 |
<p>599464 Disclosed is the use of a histone deacetylase inhibitor PXD101 (also known as belinostat or (2E)-N-Hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide in the manufacture of a medicament for the treatment of cancer, wherein said treatment comprises treatment with: (i) said histone deacetylase inhibitor; and (ii) carboplatin and paclitaxel.</p> |
| 申请公布号 |
NZ599464(A) |
申请公布日期 |
2014.03.28 |
| 申请号 |
NZ20060599464 |
申请日期 |
2006.02.03 |
| 申请人 |
TOPOTARGET UK LIMITED |
发明人 |
QIAN XIAOZHANG;PETERSEN KAMILLE DUMONG;SEHESTED MAXWELL;LICHENSTEIN HENRI;JEFFERS MIKE;RITCHIE JAMES |
| 分类号 |
A61K31/18;A61K31/00;A61K31/282;A61P35/00 |
主分类号 |
A61K31/18 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
